Infectious diseases remain among the leading causes of morbidity and mortality in the Middle East, with diseases such as pneumonia, gastroenteritis, malaria, and tuberculosis presenting a major burden in our region. The Center for Infectious Diseases Research (CIDR) at the American University of Beirut Medical Center (AUBMC) prom otes research in basic, translational, and clinical aspects of infectious diseases. The aim of the CIDR laboratory is to function as a national and regional reference laboratory with emphasis on the diagnosis of endemic and epidemic infectious diseases relevant to our region.
Click to view LIPSP newsletters from previous years: 2006, 2007, 2008, 2009, 2012 & 2013
Prevalence and Risk Factors for Prolonged Postoperative Fever in Patients with Congenital Heart Disease Undergoing Cardiovascular Surgery with Pulmonary Conduit Insertion
Viral Infections in Patients at the Children’s Cancer Center of Lebanon
Estimation of the disease burden and prevalent genotypes of rotavirus (RV) causing gastroenteritis (GE) in children < 5 years of age in Lebanon based on a sentinel hospital-based surveillance program
Prevalence and molecular characterization of Astrovirus causing gastroenteritis in children <5 years of age in Lebanon: a hospital-based surveillance program ( N.B. modified to include screening for Norovirus and Sapovirus)
Respiratory Syncytial Virus Infection In Lebanon tertiary medical center :a 10 years’ experience
Epidemiologic Surveillance of Influenza Infections in Lebanon
Epidemiology and Clinical Characteristics of Laboratory-confirmed Influenza infection in Lebanon from 2008 till 2016: A single tertiary center experience
A randomized, double-blind, placebo-controlled, 2-part study of orally administered AK0529 to evaluate the safety, tolerability, pharmacokinetics and antiviral effect of single and multiple dosing in hospitalized infants with respiratory syncytial virus infection
A phase IIIb, open, multi-country, controlled, randomized study to demonstrate the immunogenicity and safety of GSK Biologicals' meningococcal conjugate vaccine, MenACWY-TT (GSK 134612) in healthy infants, given on a 3+1 primary and booster (2, 4, 6 and 15-18 months of age), a 1+1 primary and booster (6 and 15-18 months of age) or as a single dose at 15-18 months of age
Resistant gram-negative bacterial infections in children and adolescents: incidence, epidemiology and associated risk factors
Severe Acute Respiratory Infection SARI surveillance
Ghassan Dbaibo M.D.
Professor, Director of CIDR
Ghassan Matar PhD
Professor, Laboratory Director of CIDR
Medical and Molecular Microbiology
George Araj PhD
Professor, Director of clinical Microbiology
Pathology, Microbiology & Immunology
Soha Kanj Sharara M.D.
Internal Medecine, Adult ID
Rami Mahfouz M.D., PhD
Clinical Pathology, Molecular Diagnostics
Zeina Kanafani M.D.
Internal Medecine, Adult ID
Rima Hanna Wakim M.D.
Hasan Zaraket PhD
Virology, Community Disease Control
Ghassan Awar M.D.
Nesrine Rizk M.D.
Instructor Of Clinical Specialty
Faculty of Health Sciences
Salim Adib DrPH
M.D, Dr. PH, Senior Lecturer
Epidemiology & Public Health
Mey Jurdi PhD
Professor , Dpt of Enviromental Health
Basic Medical Science
Nada Melhem PhD
Microbiology & Immunology,ID
The Center for Infectious Diseases Research is located in the heart of the city of Beirut in one of the most prestigious learning institutions in the Middle East at American University of Beirut.
00961-1-350 000 ext 5752
Office: ext 4880
Lab: Mon-Fri 8:00am-5:00pm